Leavell Investment Management Inc. Buys 25 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Leavell Investment Management Inc. lifted its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.7% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,531 shares of the medical equipment provider’s stock after purchasing an additional 25 shares during the quarter. Leavell Investment Management Inc.’s holdings in Intuitive Surgical were worth $1,735,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds also recently bought and sold shares of the company. Creekmur Asset Management LLC grew its stake in shares of Intuitive Surgical by 200.0% in the first quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock worth $25,000 after acquiring an additional 42 shares during the period. Ridgewood Investments LLC bought a new stake in Intuitive Surgical in the 2nd quarter worth approximately $26,000. Delos Wealth Advisors LLC raised its stake in Intuitive Surgical by 380.0% during the 1st quarter. Delos Wealth Advisors LLC now owns 72 shares of the medical equipment provider’s stock valued at $29,000 after buying an additional 57 shares during the last quarter. Godsey & Gibb Inc. lifted its holdings in shares of Intuitive Surgical by 140.0% during the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after buying an additional 35 shares during the period. Finally, LRI Investments LLC purchased a new position in shares of Intuitive Surgical in the 1st quarter worth $30,000. Institutional investors own 83.64% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms recently commented on ISRG. Barclays upped their price objective on Intuitive Surgical from $430.00 to $490.00 and gave the company an “overweight” rating in a research report on Thursday, July 18th. Raymond James upped their price target on shares of Intuitive Surgical from $500.00 to $540.00 and gave the company an “outperform” rating in a research report on Monday, October 14th. Piper Sandler reissued an “overweight” rating and issued a $538.00 price objective (up previously from $495.00) on shares of Intuitive Surgical in a report on Friday, October 18th. BTIG Research set a $535.00 target price on shares of Intuitive Surgical in a report on Friday, October 18th. Finally, Robert W. Baird lifted their price target on shares of Intuitive Surgical from $503.00 to $565.00 and gave the stock an “outperform” rating in a research note on Thursday, October 17th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and fourteen have assigned a buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $513.74.

Insider Buying and Selling at Intuitive Surgical

In other news, EVP Robert Desantis sold 240 shares of the stock in a transaction that occurred on Monday, August 12th. The stock was sold at an average price of $464.76, for a total value of $111,542.40. Following the sale, the executive vice president now directly owns 5,506 shares in the company, valued at approximately $2,558,968.56. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. In related news, EVP Robert Desantis sold 240 shares of the firm’s stock in a transaction dated Monday, August 12th. The shares were sold at an average price of $464.76, for a total value of $111,542.40. Following the transaction, the executive vice president now owns 5,506 shares of the company’s stock, valued at $2,558,968.56. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Amy L. Ladd sold 450 shares of Intuitive Surgical stock in a transaction dated Friday, September 13th. The shares were sold at an average price of $490.28, for a total transaction of $220,626.00. Following the sale, the director now owns 821 shares of the company’s stock, valued at $402,519.88. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 68,246 shares of company stock worth $33,839,308 over the last 90 days. Company insiders own 0.90% of the company’s stock.

Intuitive Surgical Stock Up 2.3 %

Shares of NASDAQ:ISRG opened at $536.45 on Friday. The firm has a fifty day simple moving average of $493.92 and a two-hundred day simple moving average of $451.73. The stock has a market capitalization of $191.07 billion, a P/E ratio of 86.25, a PEG ratio of 5.07 and a beta of 1.39. Intuitive Surgical, Inc. has a 52 week low of $269.49 and a 52 week high of $538.49.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, topping the consensus estimate of $1.24 by $0.32. The company had revenue of $2.04 billion for the quarter, compared to analysts’ expectations of $2.01 billion. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. On average, analysts expect that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.